Verve Therapeutics
VERV
#6643
Rank
A$0.69 B
Marketcap
$8.07
Share price
-2.36%
Change (1 day)
-59.12%
Change (1 year)

Verve Therapeutics (VERV) Fails to deliver data

Key failure to deliver metrics for Verve Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Verve Therapeutics (VERV) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Verve Therapeutics (VERV) - since 2021

Volume in USD (price x number of shares), data since 2021

Verve Therapeutics (VERV) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$20.62 M-54.14%
2023A$44.98 M-48.38%
2022A$87.14 M321.72%
2021A$20.66 M